Literature DB >> 2364166

14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia.

Y Hayashi1, C H Pui, F G Behm, A H Fuchs, S C Raimondi, G R Kitchingman, J Mirro, D L Williams.   

Abstract

The frequency and characteristics of childhood acute leukemia with a 14q32 translocation [other than the t(8;14)(q24;q32)] were determined in 335 cases of newly diagnosed acute lymphoblastic leukemia (ALL) and 105 cases of acute nonlymphoblastic leukemia (ANLL). Ten children, representing 2.3% of the entire cohort, had this abnormality (1.5% of ALL patients and 4.8% of ANLL patients). By French-American-British (FAB) criteria, 4 cases were classified as L1, 1 as L2, 2 as M1, 1 as M2, and 2 as M5. Remarkably, mixed-lineage expression was found in 6 of these 10 cases, but in only 21 of the other 430 cases without a 14q32 translocation (P less than .001). Leukemic cells from 5 of these 6 cases (4 ANLL, and 1 ALL) coexpressed CD13, a myeloid-associated antigen, and CD2, a T-cell-associated antigen; blasts from the sixth case (ALL) coexpressed CD13 and CD19, a B-lineage-associated antigen. Thus, in addition to the well-described 11q23 translocations and t(9;22), 14q32 translocations also appear to be associated with mixed lineage antigen expression. Break-points of the reciprocal chromosomes from chromosome 14 were identified in five of these cases: 1q23, 6q23-q25, 7p15, 8q11, and 12q13. Of the four mixed-lineage cases that were tested, none showed rearrangement of the immunoglobulin heavy chain (IgH) gene. This suggests that the 14q32 breakpoint does not involve the IgH gene and that an unidentified important gene may reside on 14q32.

Entities:  

Mesh:

Year:  1990        PMID: 2364166

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Early embryonal/fetal lymphopoietic ontogeny and leukemogenesis.

Authors:  G Prindull
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

2.  Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.

Authors:  Saman Abbas; Mathijs A Sanders; Annelieke Zeilemaker; Wendy M C Geertsma-Kleinekoort; Jasper E Koenders; Francois G Kavelaars; Zabiollah G Abbas; Souad Mahamoud; Isabel W T Chu; Remco Hoogenboezem; Justine K Peeters; Ellen van Drunen; Janneke van Galen; H Berna Beverloo; Bob Löwenberg; Peter J M Valk
Journal:  Haematologica       Date:  2014-01-17       Impact factor: 9.941

Review 3.  The search for a gene involved in the determination of limited duplicative capacity in human cells.

Authors:  E Calef; A Scotto d'Abusco; E Bianchi; S Gargano; A Fruscalzo
Journal:  Genetica       Date:  1994       Impact factor: 1.082

Review 4.  Development of acute lymphoblastic leukemia following treatment for acute myeloid leukemia in children with Down syndrome: A case report and retrospective review of Children's Oncology Group acute myeloid leukemia trials.

Authors:  Brianna R Murphy; Michael Roth; E Anders Kolb; Todd Alonzo; Robert Gerbing; Robert J Wells
Journal:  Pediatr Blood Cancer       Date:  2019-03-25       Impact factor: 3.167

Review 5.  Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.

Authors:  Lindsey E Montefiori; Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2021-10-23       Impact factor: 3.020

6.  Clinical characteristics and outcome of children with biphenotypic acute leukemia.

Authors:  Amal S Al-Seraihy; Tarek M Owaidah; Mouhab Ayas; Hassan El-Solh; Mohammed Al-Mahr; Ali Al-Ahmari; Asim F Belgaumi
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

Review 7.  Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia.

Authors:  R Stasi; C G Taylor; A Venditti; G Del Poeta; G Aronica; C Bastianelli; M D Simone; F Buccisano; M C Cox; A Bruno
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

8.  Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia.

Authors:  Lindsey E Montefiori; Sonja Bendig; Zhaohui Gu; Xiaolong Chen; Petri Pölönen; Xiaotu Ma; Alex Murison; Andy Zeng; Laura Garcia-Prat; Kirsten Dickerson; Ilaria Iacobucci; Sherif Abdelhamed; Ryan Hiltenbrand; Paul E Mead; Cyrus M Mehr; Beisi Xu; Zhongshan Cheng; Ti-Cheng Chang; Tamara Westover; Jing Ma; Anna Stengel; Shunsuke Kimura; Chunxu Qu; Marcus B Valentine; Marissa Rashkovan; Selina Luger; Mark R Litzow; Jacob M Rowe; Monique L den Boer; Victoria Wang; Jun Yin; Steven M Kornblau; Stephen P Hunger; Mignon L Loh; Ching-Hon Pui; Wenjian Yang; Kristine R Crews; Kathryn G Roberts; Jun J Yang; Mary V Relling; William E Evans; Wendy Stock; Elisabeth M Paietta; Adolfo A Ferrando; Jinghui Zhang; Wolfgang Kern; Torsten Haferlach; Gang Wu; John E Dick; Jeffery M Klco; Claudia Haferlach; Charles G Mullighan
Journal:  Cancer Discov       Date:  2021-06-08       Impact factor: 39.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.